Cancer-Mediated Muscle Cachexia: Etiology and Clinical Management.
Cancer-Mediated Muscle Cachexia: Etiology and Clinical Management.
复制标题
DOI：
10.1016/j.tem.2021.03.007
复制
发表时间：
2021-06
期刊：
影响因子：
--
通讯作者：
Atfi A
中科院分区：
文献类型：
--
作者：
Siff T;Parajuli P;Razzaque MS;Atfi A
Muscle cachexia has a major detrimental impact on cancer patients, being responsible for 30% of all cancer deaths. It is characterized by a debilitating loss in muscle mass and function, which ultimately deteriorates patients’ quality of life and dampens therapeutic treatment efficacy. Muscle cachexia stems from widespread alterations in whole-body metabolism as well as immunity and neuroendocrine functions, and these global defects often culminate in aberrant signaling within skeletal muscle, causing muscle protein breakdown and attendant muscle atrophy. This review summarizes recent landmark discoveries that significantly enhance our understanding of the molecular etiology of cancer-driven muscle cachexia, and further discuss emerging therapeutic approaches seeking to simultaneously target those newly-discovered mechanisms to efficiently curb this lethal syndrome.
登录
查看更多内容
影响因子：
15.9
作者：
Acharyya, S;Ladner, KJ;Guttridge, DC
通讯作者：
Guttridge, DC
影响因子：
3.4
作者：
Attie, Kenneth M.;Borgstein, Niels G.;Sherman, Matthew L.
通讯作者：
Sherman, Matthew L.
影响因子：
5.3
作者：
Bohnert, Kyle R.;Goli, Praneeth;Kumar, Ashok
通讯作者：
Kumar, Ashok
影响因子：
6.3
作者：
Biolo, Gianni;Cederholm, Tommy;Muscaritoli, Maurizio
通讯作者：
Muscaritoli, Maurizio
影响因子：
81.5
作者：
Baracos, Vickie E.;Martin, Lisa;Fearon, Kenneth C. H.
通讯作者：
Fearon, Kenneth C. H.